source
- STAT+: Anthropic deepens work with rare disease drugsNovo Nordisk sues Eli Lilly over GLP-1s, Medicare pricing plans, and more biotech news from The ReadoutSTAT · 9d ago↗ source
- STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and moreNovo Nordisk sued Eli Lilly for allegedly running “deceptive” ads to make its obesity and diabetes drugs appear more effectiveSTAT · 9d ago↗ source
- STAT+: Nabla’s new CEO on plan to gain market share in a competitive AI scribe environmentAmbient scribe developer Nabla said Brian Manning will be the Paris-based company's new CEO as it looks to grow in a highly competitive market.STAT · 9d ago